TAG ARCHIVE
POSTS TAGGED AS GLP-1 RA
Injectable Hydrogel Sustains T2 Diabetes Drug Release
January 23, 2024 | Terry Sharrer | Posted in Newsletter
Biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists
“Herein, we [at Stanford University] leverage an injectable hydrogel depot [MORE]
